Earnings calls

Medplus Health concall ledger

Every earnings call for MEDPLUS — management tone, guidance, KPIs and promise tracking, quarter by quarter.

MEDPLUS · 6 transcripts · Consumer Services · latest Q4 FY26

Q4 FY26Published 21 May 2026Call held 21 May 2026

MEDPLUS Q4 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue18,644 million

Consolidated Revenue 18644 million. Consolidated Revenue of INR18,644 million in Q4 FY26.

Q3 FY26Published 02 Feb 2026Call held 02 Feb 2026

Consolidated Revenue18,061 million

Consolidated Revenue 18061 million. Consolidated revenue reached ₹18,061 million.

Q2 FY26Published 03 Nov 2025Call held 03 Nov 2025

Consolidated Revenue16,793 million

Consolidated Revenue 16793 million. Consolidated revenue of INR16,793 million.

Q1 FY26Published 04 Aug 2025Call held 04 Aug 2025

Consolidated Revenue15,426 millionOperating EBITDA Margin4.7%

Consolidated Revenue 15426 million; Operating EBITDA Margin 4.7%. Consolidated revenue reached ₹15,426 million.

Q4 FY25Published 28 May 2025Call held 28 May 2025

Consolidated Revenue15,096 million

Consolidated Revenue 15096 million. FY25 Consolidated Revenue at INR61,361 million, up 8.6% (net basis) for pharmacy operations.

Q3 FY25Published 03 Feb 2025Call held 03 Feb 2025

Consolidated Revenue₹15,614 cr+8% YoY

Consolidated Revenue ₹15,614 cr (+8% YoY). Consolidated revenue of ₹15,614 million, up 8.3% YoY.